BBC
BBC
About Virtus Biotech Clinical Trials ETF
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
About Virtus Biotech Clinical Trials ETF
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 ERAS | Erasca, Inc. | 2.77% | 78.25K | $1.06M |
 ALMS | Alumis Inc. Common Stock | 1.92% | 24.52K | $735.08K |
 CRVS | Corvus Pharmaceuticals, Inc. | 1.60% | 33.66K | $614.60K |
 RZLT | Rezolute, Inc. | 1.34% | 156.51K | $514.93K |
 ALLO | Allogene Therapeutics, Inc. | 1.33% | 186.57K | $509.34K |
 ELVN | Enliven Therapeutics, Inc. | 1.29% | 16.71K | $494.92K |
 VTYX | Ventyx Biosciences, Inc. | 1.25% | 34.40K | $480.55K |
 ACLX | Arcellx, Inc. | 1.17% | 3.92K | $446.30K |
 RAPT | RAPT Therapeutics, Inc. | 1.16% | 7.66K | $443.74K |
 NTLA | Intellia Therapeutics, Inc. | 1.16% | 31.23K | $446.01K |
 PVLA | Palvella Therapeutics, Inc. | 1.11% | 2.86K | $423.81K |
 TYRA | Tyra Biosciences, Inc. | 1.08% | 12.45K | $413.09K |
 ORIC | ORIC Pharmaceuticals, Inc. | 1.06% | 30.03K | $405.46K |
 VIR | Vir Biotechnology, Inc. | 1.02% | 42.11K | $392.46K |
 CGON | CG Oncology, Inc. Common stock | 1.01% | 6.88K | $386.04K |
 PCVX | Vaxcyte, Inc. | 0.99% | 6.33K | $379.86K |
 BLTE | Belite Bio, Inc | 0.98% | 1.99K | $375.78K |
 RCKT | Rocket Pharmaceuticals, Inc. | 0.98% | 83.10K | $376.46K |
 CTMX | CytomX Therapeutics, Inc. | 0.96% | 67.24K | $368.46K |
 RVMD | Revolution Medicines, Inc. | 0.95% | 3.57K | $364.68K |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Canada
United Kingdom
Netherlands
Ireland
Switzerland
Germany
SingaporeSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Canada United Kingdom Netherlands Ireland Switzerland Germany SingaporeHoldings (Top 20)
ERAS
Erasca, Inc.
ALMS
Alumis Inc. Common Stock
CRVS
Corvus Pharmaceuticals, Inc.
RZLT
Rezolute, Inc.
ALLO
Allogene Therapeutics, Inc.
ELVN
Enliven Therapeutics, Inc.
VTYX
Ventyx Biosciences, Inc.
ACLX
Arcellx, Inc.
RAPT
RAPT Therapeutics, Inc.
NTLA
Intellia Therapeutics, Inc.
PVLA
Palvella Therapeutics, Inc.
TYRA
Tyra Biosciences, Inc.
ORIC
ORIC Pharmaceuticals, Inc.
VIR
Vir Biotechnology, Inc.
CGON
CG Oncology, Inc. Common stock
PCVX
Vaxcyte, Inc.
BLTE
Belite Bio, Inc
RCKT
Rocket Pharmaceuticals, Inc.
CTMX
CytomX Therapeutics, Inc.
RVMD
Revolution Medicines, Inc.